[Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs].

Hiroki Kawano, Tomohide Suzuki, Shinichi Ishii, Kanako Wakahashi, Yuko Kawano, Akiko Sada, Kentaro Minagawa, Tomofumi Takaya, Tomoya Yamashita, Ken Ichi Hirata, Kenji Koriyama, Yuichi Nagamatsu, Toshimitsu Matsui, Yoshio Katayama

Research output: Contribution to journalArticle

Abstract

We report two patients (70- and 49-year-old Japanese men) with acute exacerbation of chronic idiopathic thrombocytopenic purpura (ITP) and deep venous thrombosis of the lower extremities. Both were successfully managed with thrombopoietin receptor agonist (TPO-RA) administration. Both had ITP refractory to steroid treatment. Their immature platelet fraction (absolute-IPF) counts were increased and paralleled the platelet recoveries after TPO-RA (eltrombopag and romiplostim, respectively) without progression of thrombosis. Although ITP has recently been evaluated as a thrombophilic disorder, reports on acute exacerbation of ITP with newly diagnosed thrombosis are limited, and the pathophysiology and association between ITP and thrombosis remain to be elucidated. Moreover, the influences of TPO-RA on thrombosis are still controversial. To our knowledge, this is the first case report describing patients with exacerbation of ITP who developed thrombosis and were treated with TPO-RA. The outcomes of our cases underscore the importance of monitoring thrombosis and not delaying the initiation of anticoagulation treatment during the use of TPO-RA.

Original languageEnglish (US)
Pages (from-to)697-702
Number of pages6
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume55
Issue number6
StatePublished - Jun 2014

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of '[Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs].'. Together they form a unique fingerprint.

  • Cite this

    Kawano, H., Suzuki, T., Ishii, S., Wakahashi, K., Kawano, Y., Sada, A., Minagawa, K., Takaya, T., Yamashita, T., Hirata, K. I., Koriyama, K., Nagamatsu, Y., Matsui, T., & Katayama, Y. (2014). [Thrombopoietin receptor agonists administration for acute exacerbation of chronic idiopathic thrombocytopenic purpura and subsequent anticoagulant therapy for accompanying deep venous thrombosis of the lower limbs]. [Rinshō ketsueki] The Japanese journal of clinical hematology, 55(6), 697-702.